Biomolecular Life Holdings, Inc. has taken a significant step by filing an amended registration statement with the SEC. This action, filed on October 22, 2026, is essential for the company as it seeks to bolster its market presence and ensure compliance with regulatory standards.
Biomolecular Life Holdings, Inc. operates in the pharmaceutical preparations sector, as indicated by its SIC code 2834. The company is listed under the ticker symbol BIOM on the OTC exchange. This filing is part of a series of recent submissions aimed at maintaining transparency and adhering to regulatory requirements.
The recent SEC filing states that it is an amendment to the previous registration statement. While specific details about the amendments were not disclosed, the filing indicates a proactive approach by the company to keep its investors informed and compliant with SEC regulations.
This move may affect various stakeholders, including investors and regulatory bodies, as it highlights the company's commitment to transparency and compliance. The pharmaceutical preparations sector is known for its rigorous regulatory standards, and such filings are crucial for companies operating within it.
As for what’s next, the filing does not specify any upcoming actions or events related to this amendment.
Company Details and Compliance
Biomolecular Life Holdings, Inc. is incorporated in Delaware and has a fiscal year ending on December 31. The company operates under the SIC code 2834, which classifies it within the pharmaceutical preparations sector, known for its stringent regulatory requirements.
The filing also indicates the company's Central Index Key (CIK) number as 0001091326, which can be used for tracking all company filings with the SEC. The company's mailing and business address is listed as 888 Brickell Key Dr, #306, Miami, FL 33131, with a contact number of 805-879-9000.
Document Details
This amended registration statement includes several documents, such as EX-4.6, EX-4.7, EX-10.8, and EX-10.9, which provide further details on the company's securities and agreements. The complete submission text file is also available for review, containing detailed information about the filing.
"The filing is an important step for the company to ensure compliance with SEC regulations and to maintain transparency with its investors and stakeholders."
However, the filing does not provide specific details regarding the nature of the amendments made in this registration statement, which leaves some questions unanswered about the company's strategic direction or changes in its operational framework.